Ward Anne Sempowski 4

What Happened
Anne Sempowski Ward, a director of Vanda Pharmaceuticals, was granted 41,600 restricted stock units (RSUs) on June 4, 2026 (reported on a Form 4 filed June 8, 2026). The award is reported at $0.00 per share because it is a time-based equity grant rather than a purchase; no cash changed hands at grant.

Key Details

• Transaction date: 2026-06-04; Transaction type/code: Award (A).
• Shares granted: 41,600 RSUs; reported grant price: $0.00.
• Vesting: 100% of the shares subject to the RSU will vest on June 4, 2027, contingent on continuous service through the vesting date (per footnote).
• Amount of securities beneficially owned after the transaction: not specified in the filing.
• Filing date: 2026-06-08 (Form 4).

Context
This was a time-based RSU grant (deferred equity compensation). RSUs convert into actual shares only if/when they vest; they do not represent an immediate purchase or sale. Such awards are routine for executives and directors as compensation and do not, by themselves, indicate buying or selling sentiment.